METHOD FOR SCREENING A THERAPEUTIC AGENT FOR HEART FAILURE, FIBROSIS OR INFLAMMATION BY EYA1 GENE OVEREXPRESSION

摘要

PURPOSE: A composition containing Eya2 gene is provided to effectively prevent or treat heart failure, fibrosis or inflammation.;CONSTITUTION: A method for screening a therapeutic agent for preventing or treating heart failure, fibrosis or inflammation comprises: a step of treating test material to cells having Eya2 gene; and a step of analyzing the expression of Eya2 gene. In case of increase of Eya2 gene expression, the test material is considered as a therapeutic agent for preventing or treating heart failure, fibrosis or inflammation. A composition for preventing or treating heart failure, fibrosis or inflammation contains Eya2 gene as an active ingredient.;COPYRIGHT KIPO 2011